Four profiles of symptom change in residential Cognitive Processing Therapy.


Journal

Journal of anxiety disorders
ISSN: 1873-7897
Titre abrégé: J Anxiety Disord
Pays: Netherlands
ID NLM: 8710131

Informations de publication

Date de publication:
08 2022
Historique:
received: 17 08 2021
revised: 26 02 2022
accepted: 09 05 2022
pubmed: 8 7 2022
medline: 17 8 2022
entrez: 7 7 2022
Statut: ppublish

Résumé

A significant portion of veterans do not respond to evidence-based treatments for PTSD. Therefore, researchers have sought to predict who will respond well to trauma-focused treatment. The present study examined pre- and posttreatment symptom profiles, session-by-session change, as well as demographic and additional diagnostic information to better understand PTSD treatment response. Participants included 332 veterans undergoing residential Cognitive Processing Therapy. Latent profile analyses were computed, and four meaningful profiles emerged: Fast Responders, Steady Responders, Partial Responders, and Minimal Responders. Each profile demonstrated symptom reduction at approximately the same rate in the first half of treatment. Two specific profiles, Steady Responders and Minimal Responders, showed key clinically important differences. Both profiles demonstrated severe pretreatment PTSD symptom severity; however, in the second half of treatment, Steady Responders saw the steepest decrease in symptoms of any of the profiles while Minimal Responders saw less symptom reduction compared to all other profiles. Via a thorough examination, membership in Steady Responders compared to Minimal Responders was not associated with demographic or health variables. Results suggest that pretreatment symptom severity does not necessarily determine a client's posttreatment symptom severity. Pretreatment symptom severity did not determine outcome, though some veterans (Minimal Responders) did not experience the same symptom change and treatment effectiveness. Further identifying the factors that lead to the separation of these groups will add important information for determining treatment selection and potential obstacles to effectiveness.

Identifiants

pubmed: 35797805
pii: S0887-6185(22)00058-5
doi: 10.1016/j.janxdis.2022.102585
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

102585

Informations de copyright

Copyright © 2022. Published by Elsevier Ltd.

Auteurs

Merdijana Kovacevic (M)

Trauma Recovery Center, Cincinnati Veterans Affairs Medical Center, Cincinnati, Ohio USA. Electronic address: Merdijana_kovacevic@rush.edu.

Alison M Haney (AM)

Trauma Recovery Center, Cincinnati Veterans Affairs Medical Center, Cincinnati, Ohio USA.

Connor P Sullivan (CP)

Trauma Recovery Center, Cincinnati Veterans Affairs Medical Center, Cincinnati, Ohio USA.

Lindsay B Kramer (LB)

Department of Psychiatry and Behavioral Neuroscience, University of Cincinnati College of Medicine, Cincinnati, Ohio USA.

Kathleen M Chard (KM)

Trauma Recovery Center, Cincinnati Veterans Affairs Medical Center, Cincinnati, Ohio USA; Department of Psychiatry and Behavioral Neuroscience, University of Cincinnati College of Medicine, Cincinnati, Ohio USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH